EPORON

DRUG2 trials

Sponsors

Dong-A ST Co., Ltd.

Conditions

Anemia of Chronic Kidney DiseaseHealthy

Phase 1

To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers

Dong-A ST Co., Ltd.Healthy

Start: 2015-11-30End: 2016-03-31Target: 42Updated: 2015-10-20

Phase 3

To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)

Dong-A ST Co., Ltd.Anemia of Chronic Kidney Disease

Start: 2016-03-01End: 2021-03-31Target: 214Updated: 2019-12-10